SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-026600
Filing Date
2019-07-29
Accepted
2019-07-29 16:20:33
Documents
70
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20190630.htm   iXBRL 10-Q 1806259
2 EX-10.1 crsp-ex101_284.htm EX-10.1 118470
3 EX-10.2 crsp-ex102_285.htm EX-10.2 988687
4 EX-31.1 crsp-ex311_8.htm EX-31.1 19185
5 EX-31.2 crsp-ex312_7.htm EX-31.2 19440
6 EX-32.1 crsp-ex321_6.htm EX-32.1 7752
  Complete submission text file 0001564590-19-026600.txt   7860844

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA crsp-20190630.xsd EX-101.SCH 51859
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20190630_cal.xml EX-101.CAL 51511
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20190630_def.xml EX-101.DEF 141445
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20190630_lab.xml EX-101.LAB 394949
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20190630_pre.xml EX-101.PRE 298138
12 EXTRACTED XBRL INSTANCE DOCUMENT crsp-10q_20190630_htm.xml XML 1161229
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 19981437
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences